| 2.2 |
6.6 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 1.4 |
7.1 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 1.4 |
6.8 |
GO:2000065 |
negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
| 1.3 |
3.8 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 1.2 |
3.6 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 1.0 |
3.0 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.9 |
2.6 |
GO:1903279 |
regulation of calcium:sodium antiporter activity(GO:1903279) |
| 0.9 |
2.6 |
GO:1904139 |
microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
| 0.7 |
4.5 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.7 |
2.2 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.7 |
2.0 |
GO:0051933 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.7 |
4.0 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.6 |
1.8 |
GO:0090258 |
negative regulation of mitochondrial fission(GO:0090258) |
| 0.6 |
2.3 |
GO:2000525 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.6 |
1.1 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.5 |
3.8 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.5 |
1.0 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.5 |
2.1 |
GO:0090365 |
regulation of mRNA modification(GO:0090365) |
| 0.5 |
2.0 |
GO:0098735 |
positive regulation of guanylate cyclase activity(GO:0031284) positive regulation of the force of heart contraction(GO:0098735) regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) |
| 0.5 |
1.5 |
GO:0002447 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) regulation of eosinophil activation(GO:1902566) |
| 0.5 |
1.5 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 0.5 |
1.4 |
GO:0035622 |
intrahepatic bile duct development(GO:0035622) |
| 0.5 |
1.9 |
GO:0035624 |
receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.4 |
2.1 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.4 |
1.3 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.4 |
4.1 |
GO:0015824 |
proline transport(GO:0015824) |
| 0.4 |
2.0 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.4 |
2.3 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.4 |
1.5 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.4 |
1.1 |
GO:0007521 |
muscle cell fate determination(GO:0007521) mammary placode formation(GO:0060596) |
| 0.4 |
3.3 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.4 |
1.8 |
GO:2001204 |
regulation of osteoclast development(GO:2001204) |
| 0.4 |
3.9 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.3 |
1.7 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.3 |
1.0 |
GO:0035633 |
maintenance of blood-brain barrier(GO:0035633) |
| 0.3 |
0.3 |
GO:0003219 |
cardiac right ventricle formation(GO:0003219) |
| 0.3 |
1.7 |
GO:0015788 |
UDP-N-acetylglucosamine transport(GO:0015788) |
| 0.3 |
1.0 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 0.3 |
1.0 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.3 |
1.6 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.3 |
0.6 |
GO:0042634 |
regulation of hair cycle(GO:0042634) positive regulation of hair cycle(GO:0042635) regulation of hair follicle development(GO:0051797) positive regulation of hair follicle development(GO:0051798) |
| 0.3 |
0.6 |
GO:0061324 |
canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901963) |
| 0.3 |
1.6 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.3 |
1.5 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.3 |
0.9 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.3 |
0.9 |
GO:0001866 |
NK T cell proliferation(GO:0001866) regulation of natural killer cell proliferation(GO:0032817) positive regulation of natural killer cell proliferation(GO:0032819) |
| 0.3 |
0.9 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.3 |
0.9 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 0.3 |
2.1 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.3 |
1.8 |
GO:0015879 |
carnitine transport(GO:0015879) |
| 0.3 |
1.2 |
GO:0071499 |
response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
| 0.3 |
1.2 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.3 |
2.0 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.3 |
2.3 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.3 |
1.4 |
GO:2000680 |
regulation of rubidium ion transport(GO:2000680) |
| 0.3 |
0.8 |
GO:0032430 |
positive regulation of phospholipase A2 activity(GO:0032430) |
| 0.3 |
1.7 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) |
| 0.3 |
1.1 |
GO:0051593 |
response to folic acid(GO:0051593) |
| 0.3 |
1.4 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.3 |
1.3 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.3 |
1.0 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.3 |
1.8 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.3 |
1.0 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) succinate transport(GO:0015744) citrate transport(GO:0015746) |
| 0.3 |
0.3 |
GO:0072338 |
creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
| 0.3 |
1.3 |
GO:0051006 |
positive regulation of lipoprotein lipase activity(GO:0051006) |
| 0.2 |
1.0 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.2 |
1.7 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.2 |
0.7 |
GO:0014891 |
striated muscle atrophy(GO:0014891) |
| 0.2 |
1.0 |
GO:2001137 |
positive regulation of endocytic recycling(GO:2001137) |
| 0.2 |
1.9 |
GO:0097460 |
ferrous iron import into cell(GO:0097460) |
| 0.2 |
0.7 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.2 |
1.2 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.2 |
0.7 |
GO:0006533 |
aspartate catabolic process(GO:0006533) D-amino acid catabolic process(GO:0019478) |
| 0.2 |
0.7 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.2 |
0.7 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.2 |
0.7 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.2 |
0.7 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.2 |
0.7 |
GO:1904049 |
regulation of spontaneous neurotransmitter secretion(GO:1904048) negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.2 |
0.7 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.2 |
0.9 |
GO:0010694 |
positive regulation of alkaline phosphatase activity(GO:0010694) |
| 0.2 |
0.4 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.2 |
0.2 |
GO:0070885 |
negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.2 |
1.0 |
GO:0072602 |
interleukin-4 secretion(GO:0072602) |
| 0.2 |
0.6 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.2 |
0.8 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.2 |
0.8 |
GO:2000974 |
negative regulation of pro-B cell differentiation(GO:2000974) |
| 0.2 |
2.2 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.2 |
0.8 |
GO:0045002 |
double-strand break repair via single-strand annealing(GO:0045002) |
| 0.2 |
3.0 |
GO:0017144 |
drug metabolic process(GO:0017144) |
| 0.2 |
0.6 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 0.2 |
0.8 |
GO:0060351 |
cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.2 |
1.2 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.2 |
1.7 |
GO:2001214 |
positive regulation of vasculogenesis(GO:2001214) |
| 0.2 |
1.3 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.2 |
0.6 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.2 |
1.5 |
GO:2000809 |
positive regulation of synaptic vesicle clustering(GO:2000809) |
| 0.2 |
1.3 |
GO:0035188 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.2 |
0.7 |
GO:0015697 |
quaternary ammonium group transport(GO:0015697) |
| 0.2 |
0.5 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.2 |
1.2 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.2 |
2.5 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.2 |
0.5 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.2 |
0.5 |
GO:0090032 |
operant conditioning(GO:0035106) negative regulation of steroid hormone biosynthetic process(GO:0090032) |
| 0.2 |
0.9 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) |
| 0.2 |
0.7 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.2 |
0.5 |
GO:0048352 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) |
| 0.2 |
0.5 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.2 |
0.7 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.2 |
0.5 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.2 |
0.3 |
GO:2000705 |
regulation of dense core granule biogenesis(GO:2000705) |
| 0.2 |
0.5 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.2 |
0.3 |
GO:0032026 |
response to magnesium ion(GO:0032026) |
| 0.2 |
0.6 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.2 |
0.5 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.2 |
0.5 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.2 |
0.5 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.2 |
0.6 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.2 |
0.8 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.2 |
1.7 |
GO:0009437 |
carnitine metabolic process(GO:0009437) |
| 0.2 |
0.9 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 0.1 |
0.4 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
| 0.1 |
0.6 |
GO:0042167 |
heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 |
0.4 |
GO:0061043 |
regulation of vascular wound healing(GO:0061043) |
| 0.1 |
0.3 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.1 |
0.9 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.1 |
1.4 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.1 |
0.4 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.1 |
0.6 |
GO:0006549 |
isoleucine metabolic process(GO:0006549) |
| 0.1 |
0.1 |
GO:0002086 |
diaphragm contraction(GO:0002086) |
| 0.1 |
2.8 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 |
0.5 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.1 |
0.5 |
GO:0035934 |
corticosterone secretion(GO:0035934) |
| 0.1 |
0.4 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.1 |
1.2 |
GO:0043206 |
extracellular fibril organization(GO:0043206) |
| 0.1 |
2.2 |
GO:2001014 |
regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.1 |
0.4 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.1 |
0.5 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.1 |
0.1 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.1 |
0.4 |
GO:0003273 |
cell migration involved in endocardial cushion formation(GO:0003273) |
| 0.1 |
0.9 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 |
1.4 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.1 |
0.5 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.1 |
1.7 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 |
1.4 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.1 |
1.0 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.1 |
0.9 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.1 |
0.5 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
| 0.1 |
0.5 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.1 |
0.2 |
GO:0010886 |
regulation of cholesterol storage(GO:0010885) positive regulation of cholesterol storage(GO:0010886) |
| 0.1 |
0.4 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.1 |
0.5 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.1 |
1.5 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 0.1 |
1.6 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.1 |
0.5 |
GO:1900864 |
positive regulation of translational fidelity(GO:0045903) mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.1 |
0.2 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.1 |
0.8 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.1 |
0.6 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.1 |
2.7 |
GO:0022038 |
corpus callosum development(GO:0022038) |
| 0.1 |
0.3 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
| 0.1 |
0.3 |
GO:0010752 |
signal complex assembly(GO:0007172) regulation of cGMP-mediated signaling(GO:0010752) |
| 0.1 |
0.8 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.1 |
0.9 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 |
0.3 |
GO:0046168 |
glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.1 |
0.4 |
GO:0042364 |
water-soluble vitamin biosynthetic process(GO:0042364) |
| 0.1 |
0.1 |
GO:0014738 |
regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
| 0.1 |
0.5 |
GO:0010991 |
regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.1 |
0.5 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.1 |
0.3 |
GO:1903546 |
receptor localization to nonmotile primary cilium(GO:0097500) protein localization to photoreceptor outer segment(GO:1903546) |
| 0.1 |
0.4 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.1 |
0.1 |
GO:0051958 |
methotrexate transport(GO:0051958) |
| 0.1 |
1.0 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.1 |
2.3 |
GO:0034340 |
response to type I interferon(GO:0034340) |
| 0.1 |
1.6 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.1 |
0.3 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.1 |
0.5 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.1 |
0.3 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
| 0.1 |
0.1 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.1 |
0.3 |
GO:0042420 |
dopamine catabolic process(GO:0042420) |
| 0.1 |
0.4 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.1 |
0.8 |
GO:1901550 |
regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
| 0.1 |
0.4 |
GO:0006207 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.1 |
1.6 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.1 |
1.0 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 |
0.4 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) cytosol to ER transport(GO:0046967) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.1 |
0.5 |
GO:0036438 |
positive regulation of heterotypic cell-cell adhesion(GO:0034116) maintenance of lens transparency(GO:0036438) |
| 0.1 |
0.2 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.1 |
0.6 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.1 |
0.3 |
GO:1901799 |
negative regulation of proteasomal protein catabolic process(GO:1901799) |
| 0.1 |
0.8 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.1 |
0.7 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.1 |
0.5 |
GO:0034134 |
response to peptidoglycan(GO:0032494) toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.1 |
0.4 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.1 |
0.2 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.1 |
0.5 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.1 |
0.4 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.1 |
0.6 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 |
2.8 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.1 |
3.6 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.1 |
0.6 |
GO:1901072 |
N-acetylglucosamine catabolic process(GO:0006046) glucosamine-containing compound catabolic process(GO:1901072) |
| 0.1 |
0.3 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 |
0.6 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 |
0.4 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) resolution of recombination intermediates(GO:0071139) |
| 0.1 |
0.3 |
GO:0048859 |
formation of anatomical boundary(GO:0048859) |
| 0.1 |
0.5 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.1 |
2.8 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 |
0.4 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.1 |
0.3 |
GO:0015938 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 0.1 |
0.3 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.1 |
0.4 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 |
0.8 |
GO:0044144 |
regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 0.1 |
0.4 |
GO:1901524 |
regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
| 0.1 |
0.2 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.1 |
1.0 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 |
2.4 |
GO:0097320 |
membrane tubulation(GO:0097320) |
| 0.1 |
1.1 |
GO:0035751 |
regulation of lysosomal lumen pH(GO:0035751) |
| 0.1 |
0.7 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.1 |
0.1 |
GO:1900020 |
regulation of activation of Janus kinase activity(GO:0010533) regulation of activation of JAK2 kinase activity(GO:0010534) regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.1 |
0.4 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.1 |
0.3 |
GO:0031038 |
myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 0.1 |
0.3 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.1 |
2.2 |
GO:0010043 |
response to zinc ion(GO:0010043) |
| 0.1 |
0.6 |
GO:0071474 |
cellular hyperosmotic response(GO:0071474) |
| 0.1 |
2.8 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.1 |
0.3 |
GO:0042538 |
hyperosmotic salinity response(GO:0042538) |
| 0.1 |
0.3 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 |
0.2 |
GO:0016553 |
adenosine to inosine editing(GO:0006382) base conversion or substitution editing(GO:0016553) |
| 0.1 |
0.4 |
GO:0010359 |
regulation of anion channel activity(GO:0010359) |
| 0.1 |
2.5 |
GO:0001964 |
startle response(GO:0001964) |
| 0.1 |
0.5 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.1 |
0.8 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.1 |
0.3 |
GO:0008078 |
mesodermal cell migration(GO:0008078) |
| 0.1 |
0.2 |
GO:0050857 |
positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.1 |
0.2 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.1 |
0.6 |
GO:0060662 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.1 |
2.4 |
GO:0071480 |
cellular response to gamma radiation(GO:0071480) |
| 0.1 |
0.4 |
GO:0021898 |
commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
| 0.1 |
0.9 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 |
0.6 |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) negative regulation of sprouting angiogenesis(GO:1903671) |
| 0.1 |
1.3 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.1 |
1.1 |
GO:0045047 |
protein targeting to ER(GO:0045047) |
| 0.1 |
0.8 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.1 |
0.2 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.1 |
0.4 |
GO:0060510 |
Type II pneumocyte differentiation(GO:0060510) |
| 0.1 |
0.5 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 |
0.5 |
GO:0031666 |
positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.1 |
0.3 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.1 |
0.6 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.1 |
0.4 |
GO:0097369 |
sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 |
0.1 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.1 |
0.3 |
GO:0048007 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.1 |
0.9 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.1 |
0.5 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.1 |
0.8 |
GO:0002031 |
G-protein coupled receptor internalization(GO:0002031) |
| 0.1 |
0.1 |
GO:0035553 |
oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.1 |
0.6 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.1 |
0.5 |
GO:0051354 |
negative regulation of oxidoreductase activity(GO:0051354) |
| 0.1 |
0.4 |
GO:0051561 |
calcium ion transmembrane import into mitochondrion(GO:0036444) positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.1 |
0.4 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.1 |
0.4 |
GO:1902847 |
macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of tau-protein kinase activity(GO:1902949) |
| 0.1 |
0.1 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) |
| 0.1 |
0.8 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.1 |
4.7 |
GO:0030279 |
negative regulation of ossification(GO:0030279) |
| 0.1 |
0.5 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.1 |
0.5 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.1 |
2.1 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.1 |
0.2 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.1 |
0.8 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.1 |
0.3 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.1 |
0.1 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.1 |
0.2 |
GO:0032914 |
transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.1 |
0.2 |
GO:0071156 |
regulation of cell cycle arrest(GO:0071156) |
| 0.1 |
0.3 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.1 |
1.3 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.1 |
0.3 |
GO:1903020 |
positive regulation of glycoprotein metabolic process(GO:1903020) |
| 0.1 |
1.4 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.1 |
0.3 |
GO:0070627 |
ferrous iron import(GO:0070627) |
| 0.1 |
0.5 |
GO:0035767 |
endothelial cell chemotaxis(GO:0035767) |
| 0.1 |
0.3 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.1 |
0.5 |
GO:0060768 |
epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.1 |
0.3 |
GO:0014053 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) negative regulation of dopamine secretion(GO:0033602) |
| 0.1 |
0.5 |
GO:0010039 |
response to iron ion(GO:0010039) |
| 0.1 |
0.7 |
GO:0032329 |
serine transport(GO:0032329) |
| 0.1 |
0.6 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.1 |
0.3 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.1 |
1.0 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.1 |
0.4 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.1 |
0.6 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 |
0.2 |
GO:0045346 |
regulation of MHC class II biosynthetic process(GO:0045346) negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.1 |
0.4 |
GO:0046103 |
ADP biosynthetic process(GO:0006172) inosine biosynthetic process(GO:0046103) |
| 0.1 |
0.3 |
GO:0014819 |
regulation of skeletal muscle contraction(GO:0014819) |
| 0.1 |
1.6 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.1 |
0.2 |
GO:0060785 |
regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
| 0.1 |
0.7 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.1 |
0.3 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.1 |
1.2 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 |
0.4 |
GO:0046686 |
response to cadmium ion(GO:0046686) |
| 0.1 |
0.2 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.1 |
0.7 |
GO:0030449 |
regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
| 0.1 |
1.4 |
GO:0010866 |
regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.1 |
0.2 |
GO:0097461 |
ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
| 0.1 |
0.2 |
GO:0002002 |
regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
| 0.1 |
0.2 |
GO:0030262 |
cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
| 0.1 |
0.6 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.1 |
0.4 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
0.3 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.1 |
0.5 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.1 |
0.3 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.1 |
0.2 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
| 0.1 |
0.2 |
GO:2001045 |
closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.1 |
0.6 |
GO:0035999 |
tetrahydrofolate interconversion(GO:0035999) |
| 0.1 |
0.5 |
GO:0097205 |
renal filtration(GO:0097205) |
| 0.1 |
0.1 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.1 |
1.4 |
GO:0001954 |
positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.1 |
0.5 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 |
0.3 |
GO:0032201 |
telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.1 |
0.7 |
GO:0042733 |
embryonic digit morphogenesis(GO:0042733) |
| 0.1 |
0.6 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 |
0.3 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.1 |
0.3 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 |
0.4 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
1.9 |
GO:0042632 |
cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
| 0.1 |
0.7 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.1 |
0.9 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.1 |
0.8 |
GO:0032331 |
negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.1 |
0.2 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
| 0.1 |
1.2 |
GO:0006829 |
zinc II ion transport(GO:0006829) |
| 0.1 |
0.2 |
GO:0002921 |
regulation of type I hypersensitivity(GO:0001810) negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) negative regulation of humoral immune response(GO:0002921) negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) type I hypersensitivity(GO:0016068) |
| 0.1 |
0.5 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
0.7 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 0.1 |
0.4 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.1 |
0.5 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.1 |
0.5 |
GO:0097421 |
liver regeneration(GO:0097421) |
| 0.1 |
0.2 |
GO:0048245 |
eosinophil chemotaxis(GO:0048245) |
| 0.1 |
0.2 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.1 |
0.5 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.1 |
0.2 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.1 |
1.9 |
GO:0010595 |
positive regulation of endothelial cell migration(GO:0010595) |
| 0.1 |
0.1 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 0.1 |
0.2 |
GO:0035511 |
oxidative DNA demethylation(GO:0035511) |
| 0.1 |
0.6 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.1 |
0.2 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.1 |
0.4 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.1 |
1.6 |
GO:0015909 |
long-chain fatty acid transport(GO:0015909) |
| 0.1 |
1.5 |
GO:0016101 |
diterpenoid metabolic process(GO:0016101) |
| 0.0 |
0.4 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 |
0.2 |
GO:0007195 |
adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 0.0 |
0.7 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.0 |
0.1 |
GO:0045988 |
negative regulation of striated muscle contraction(GO:0045988) |
| 0.0 |
0.1 |
GO:0045448 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.0 |
0.2 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.0 |
0.5 |
GO:1900364 |
negative regulation of mRNA 3'-end processing(GO:0031441) regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.0 |
0.7 |
GO:0014898 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.0 |
0.1 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.0 |
0.5 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
0.4 |
GO:0043247 |
protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
| 0.0 |
0.7 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.0 |
0.4 |
GO:0046835 |
carbohydrate phosphorylation(GO:0046835) |
| 0.0 |
1.4 |
GO:0034314 |
Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.0 |
0.2 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.0 |
0.2 |
GO:0010165 |
response to X-ray(GO:0010165) |
| 0.0 |
0.3 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.0 |
0.5 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.0 |
0.3 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 0.0 |
0.3 |
GO:0035641 |
locomotory exploration behavior(GO:0035641) |
| 0.0 |
0.6 |
GO:0032784 |
regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.0 |
0.1 |
GO:0019336 |
phenol-containing compound catabolic process(GO:0019336) |
| 0.0 |
0.2 |
GO:1901838 |
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.0 |
0.2 |
GO:0060193 |
positive regulation of lipase activity(GO:0060193) |
| 0.0 |
0.9 |
GO:0001702 |
gastrulation with mouth forming second(GO:0001702) |
| 0.0 |
0.5 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 |
0.2 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.0 |
0.2 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.0 |
0.4 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.0 |
0.2 |
GO:0070257 |
regulation of mucus secretion(GO:0070255) positive regulation of mucus secretion(GO:0070257) |
| 0.0 |
0.0 |
GO:0033239 |
negative regulation of cellular amine metabolic process(GO:0033239) |
| 0.0 |
0.5 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.0 |
0.1 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.0 |
0.4 |
GO:0016575 |
histone deacetylation(GO:0016575) |
| 0.0 |
0.1 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.0 |
2.5 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.0 |
2.3 |
GO:0048709 |
oligodendrocyte differentiation(GO:0048709) |
| 0.0 |
0.5 |
GO:0032438 |
melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
| 0.0 |
0.4 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.0 |
0.2 |
GO:2000767 |
positive regulation of cytoplasmic translation(GO:2000767) |
| 0.0 |
0.2 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.0 |
1.3 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.0 |
0.4 |
GO:0032720 |
negative regulation of tumor necrosis factor production(GO:0032720) |
| 0.0 |
0.2 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.0 |
0.4 |
GO:0009081 |
branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 |
0.1 |
GO:0009415 |
response to water(GO:0009415) |
| 0.0 |
0.1 |
GO:0035696 |
monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 0.0 |
0.4 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 |
0.1 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.0 |
0.1 |
GO:1904355 |
positive regulation of telomere capping(GO:1904355) |
| 0.0 |
0.2 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.0 |
0.2 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.0 |
0.5 |
GO:0042474 |
middle ear morphogenesis(GO:0042474) |
| 0.0 |
0.9 |
GO:0051216 |
cartilage development(GO:0051216) |
| 0.0 |
0.3 |
GO:0086010 |
membrane depolarization during action potential(GO:0086010) |
| 0.0 |
0.1 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.0 |
0.1 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.0 |
0.2 |
GO:2000191 |
regulation of fatty acid transport(GO:2000191) |
| 0.0 |
0.7 |
GO:0003416 |
endochondral bone growth(GO:0003416) |
| 0.0 |
1.1 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 |
0.5 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.0 |
1.2 |
GO:0045739 |
positive regulation of DNA repair(GO:0045739) |
| 0.0 |
0.4 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
| 0.0 |
0.6 |
GO:0061036 |
positive regulation of cartilage development(GO:0061036) |
| 0.0 |
0.2 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.0 |
0.4 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.0 |
0.3 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.0 |
0.2 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.0 |
0.3 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 |
0.1 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.0 |
0.2 |
GO:0015817 |
histidine transport(GO:0015817) |
| 0.0 |
0.6 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.0 |
0.6 |
GO:0032968 |
positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.0 |
0.2 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.0 |
0.1 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.0 |
1.1 |
GO:2000134 |
negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.0 |
0.9 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.0 |
0.4 |
GO:0033344 |
cholesterol efflux(GO:0033344) |
| 0.0 |
0.4 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.0 |
0.1 |
GO:0042822 |
vitamin B6 metabolic process(GO:0042816) pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.0 |
0.2 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.0 |
0.7 |
GO:2000179 |
positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.0 |
0.2 |
GO:0046348 |
amino sugar catabolic process(GO:0046348) |
| 0.0 |
0.2 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.0 |
0.6 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.0 |
0.1 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.0 |
0.1 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 0.0 |
0.5 |
GO:0060259 |
regulation of feeding behavior(GO:0060259) |
| 0.0 |
0.7 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.0 |
0.2 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.0 |
0.2 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.0 |
1.0 |
GO:0048002 |
antigen processing and presentation of peptide antigen(GO:0048002) |
| 0.0 |
0.1 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.0 |
0.3 |
GO:1990267 |
response to transition metal nanoparticle(GO:1990267) |
| 0.0 |
0.1 |
GO:0050716 |
regulation of interleukin-1 secretion(GO:0050704) regulation of interleukin-1 beta secretion(GO:0050706) positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
| 0.0 |
0.1 |
GO:1905049 |
negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
| 0.0 |
0.1 |
GO:0046078 |
pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
| 0.0 |
0.1 |
GO:0010730 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.0 |
0.2 |
GO:0051560 |
mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.0 |
0.1 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.0 |
0.2 |
GO:0002082 |
regulation of oxidative phosphorylation(GO:0002082) |
| 0.0 |
0.1 |
GO:0051771 |
negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.0 |
0.4 |
GO:0042993 |
positive regulation of transcription factor import into nucleus(GO:0042993) |
| 0.0 |
0.1 |
GO:0043928 |
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.0 |
0.0 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
| 0.0 |
0.1 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.0 |
0.2 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.0 |
0.2 |
GO:0045191 |
regulation of isotype switching(GO:0045191) |
| 0.0 |
0.2 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.0 |
0.5 |
GO:0019915 |
lipid storage(GO:0019915) |
| 0.0 |
0.3 |
GO:0045161 |
neuronal ion channel clustering(GO:0045161) |
| 0.0 |
0.2 |
GO:0001516 |
prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.0 |
0.2 |
GO:1902287 |
semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
| 0.0 |
0.8 |
GO:0051973 |
positive regulation of telomerase activity(GO:0051973) |
| 0.0 |
0.1 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.0 |
1.1 |
GO:0010811 |
positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.0 |
0.1 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.0 |
0.1 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.0 |
0.4 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.0 |
0.2 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 |
0.4 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.0 |
0.1 |
GO:0030813 |
positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.0 |
0.4 |
GO:0000132 |
establishment of mitotic spindle orientation(GO:0000132) |
| 0.0 |
0.1 |
GO:0032799 |
low-density lipoprotein receptor particle metabolic process(GO:0032799) low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
| 0.0 |
0.3 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.0 |
0.2 |
GO:1904152 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.0 |
0.3 |
GO:0051897 |
positive regulation of protein kinase B signaling(GO:0051897) |
| 0.0 |
0.4 |
GO:0010830 |
regulation of myotube differentiation(GO:0010830) |
| 0.0 |
0.2 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.0 |
0.1 |
GO:0042510 |
tyrosine phosphorylation of Stat1 protein(GO:0042508) regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
| 0.0 |
0.1 |
GO:0060398 |
regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.0 |
0.6 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 |
0.1 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 |
0.0 |
GO:0033262 |
regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 0.0 |
0.2 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.0 |
0.2 |
GO:1901798 |
positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.0 |
0.1 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.0 |
0.4 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.4 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.0 |
2.4 |
GO:0008654 |
phospholipid biosynthetic process(GO:0008654) |
| 0.0 |
0.1 |
GO:0009838 |
abscission(GO:0009838) |
| 0.0 |
0.0 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.0 |
0.7 |
GO:0043525 |
positive regulation of neuron apoptotic process(GO:0043525) |
| 0.0 |
0.1 |
GO:0042891 |
antibiotic transport(GO:0042891) |
| 0.0 |
0.4 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.0 |
0.3 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.0 |
0.3 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.0 |
0.1 |
GO:1901675 |
response to methylglyoxal(GO:0051595) negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.0 |
0.2 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.0 |
0.2 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.0 |
0.1 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.2 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 0.0 |
1.9 |
GO:0010876 |
lipid localization(GO:0010876) |
| 0.0 |
0.5 |
GO:0030968 |
endoplasmic reticulum unfolded protein response(GO:0030968) |
| 0.0 |
0.1 |
GO:0021592 |
fourth ventricle development(GO:0021592) |
| 0.0 |
1.7 |
GO:0000423 |
macromitophagy(GO:0000423) |
| 0.0 |
0.2 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.0 |
0.4 |
GO:0035904 |
aorta development(GO:0035904) |
| 0.0 |
0.2 |
GO:0019395 |
fatty acid oxidation(GO:0019395) |
| 0.0 |
0.0 |
GO:0002281 |
macrophage activation involved in immune response(GO:0002281) |
| 0.0 |
0.2 |
GO:0071353 |
response to interleukin-4(GO:0070670) cellular response to interleukin-4(GO:0071353) |
| 0.0 |
0.8 |
GO:0072332 |
intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.0 |
0.3 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 |
0.2 |
GO:0022617 |
extracellular matrix disassembly(GO:0022617) |
| 0.0 |
0.0 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.0 |
0.2 |
GO:0050728 |
negative regulation of inflammatory response(GO:0050728) |
| 0.0 |
0.1 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.0 |
0.1 |
GO:0002098 |
tRNA wobble uridine modification(GO:0002098) |
| 0.0 |
0.1 |
GO:0010807 |
regulation of synaptic vesicle priming(GO:0010807) |
| 0.0 |
0.1 |
GO:2000758 |
positive regulation of histone acetylation(GO:0035066) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
| 0.0 |
0.8 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.0 |
0.3 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 |
0.2 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.0 |
0.0 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.0 |
0.1 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.0 |
0.1 |
GO:0090085 |
regulation of protein deubiquitination(GO:0090085) |
| 0.0 |
0.1 |
GO:0046133 |
pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.0 |
0.2 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.0 |
0.0 |
GO:1903792 |
negative regulation of anion transport(GO:1903792) |
| 0.0 |
0.2 |
GO:0043153 |
photoperiodism(GO:0009648) entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.0 |
0.3 |
GO:0007094 |
mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
| 0.0 |
0.2 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.0 |
0.1 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.0 |
0.1 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.0 |
0.1 |
GO:0070129 |
regulation of mitochondrial translation(GO:0070129) |
| 0.0 |
0.3 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
| 0.0 |
0.2 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.0 |
0.1 |
GO:0000479 |
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
| 0.0 |
0.2 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 |
0.1 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.0 |
0.1 |
GO:0002063 |
chondrocyte development(GO:0002063) |
| 0.0 |
0.1 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.0 |
0.3 |
GO:0008542 |
visual learning(GO:0008542) |
| 0.0 |
0.1 |
GO:0030819 |
positive regulation of cAMP metabolic process(GO:0030816) positive regulation of cAMP biosynthetic process(GO:0030819) |
| 0.0 |
0.0 |
GO:0071816 |
protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
